{"id":{"repo_id":"wayne-thes","oai_identifier":"oai:digitalcommons.wayne.edu:oa_dissertations-1888"},"canonical_url":"https://search.dev.ndltd.org/etd/wayne-thes/oai:digitalcommons.wayne.edu:oa_dissertations-1888","repository":{"repo_id":"wayne-thes","name":"Wayne State University","base_url":"https://digitalcommons.wayne.edu/do/oai/"},"display":{"title":"Isolation And Characterization Of Natural Alpha-Glucosidase Inhibitors From Antioxidant Rich Red Wine Grapes (vitis Vinifera)","abstract":"<p> <strong>Background:</strong> Diabetes is currently a global public health problem affecting people at all ages. Dietary antioxidants have been associated with a reduced risk of type 2 diabetes. Grape pomace contains considerable amounts of polyphenols and it has been reported to exhibit an inhibitory activity against alpha- glucosidases. Alpha-glucosidases, in turn, play a major role in controlling starch digestion and therefore postprandial blood glucose, a target for diabetes management. </p> <p> <strong>Objective:</strong> This study aims to investigate the anti-diabetes potential of a selection of six grape pomaces and prepare and purify active components in the active variety that specifically inhibit intestinal alpha-glucosidases. The study was also designed to evaluate the applicability of the isolated active components as natural inhibitors of alpha-glucosidases. </p> <p> <strong>Methods:</strong> Chambourcin, Merlot, Norton, Petit Verdot, Syrah and Tinta Cao red wine grape pomace extracts were assessed for their rat intestinal alpha-glucosidase inhibiting activity and antioxidant properties via biochemical assays and UV detection. Then, the grape pomace variety shown to potently inhibit the enzyme was subjected to bioactivity-guided fractionation and the isolated active component was identified via analytical chemistry techniques. The characterized compound was then tested for functional food applicability via stability, enzyme specificity and cytotoxicity testing. </p> <p> <strong>Results:</strong> Tinta Cao grape pomace extract was the most potent alpha-glucosidase inhibiting variety and possessed a remarkable antioxidant activity, both properties of which appeared to be correlated. HPLC analysis did not yield an antioxidant responsible for the observed trend. Hence, bioactivity-guided fractionation of the extract was pursued, yielding a pure active compound that was determined to be D-Glucopyranose 6-{(2E)-3-(4-Hydroxyphenyl)prop-2-enoate}, which also exhibited a strong antioxidant activity. Further testing indicated that the compound inhibits alpha-glucosidase and not alpha-amylase, and specifically inhibits the maltase and isomaltase moieties of alpha-glucosidase, in a dose-dependent fashion. The compound was fairly stable under different environmental and storage conditions, and it was also not cytotoxic to animal cells.</p> <p> <strong>Conclusion:</strong> Red grape pomace, namely Tinta Cao, is a promising bioresource for the future development of a food-derived antidiabetic agent. At least one component, D-Glucopyranose 6-{(2E)-3-(4-Hydroxyphenyl)prop-2-enoate}, isolated from Tinta Cao grape pomace appears to potently and specifically inhibit mammalian intestinal alpha-glucosidases while exhibiting a notable ability to quench free radicals. It may thus represent an alternative future strategy for diabetes management and a novel antioxidant compound. Pre-clinical and clinical testing will validate the obtained results in vivo.</p>","abstract_html":"&lt;p&gt; &lt;strong&gt;Background:&lt;/strong&gt; Diabetes is currently a global public health problem affecting people at all ages. Dietary antioxidants have been associated with a reduced risk of type 2 diabetes. Grape pomace contains considerable amounts of polyphenols and it has been reported to exhibit an inhibitory activity against alpha- glucosidases. Alpha-glucosidases, in turn, play a major role in controlling starch digestion and therefore postprandial blood glucose, a target for diabetes management. &lt;/p&gt; &lt;p&gt; &lt;strong&gt;Objective:&lt;/strong&gt; This study aims to investigate the anti-diabetes potential of a selection of six grape pomaces and prepare and purify active components in the active variety that specifically inhibit intestinal alpha-glucosidases. The study was also designed to evaluate the applicability of the isolated active components as natural inhibitors of alpha-glucosidases. &lt;/p&gt; &lt;p&gt; &lt;strong&gt;Methods:&lt;/strong&gt; Chambourcin, Merlot, Norton, Petit Verdot, Syrah and Tinta Cao red wine grape pomace extracts were assessed for their rat intestinal alpha-glucosidase inhibiting activity and antioxidant properties via biochemical assays and UV detection. Then, the grape pomace variety shown to potently inhibit the enzyme was subjected to bioactivity-guided fractionation and the isolated active component was identified via analytical chemistry techniques. The characterized compound was then tested for functional food applicability via stability, enzyme specificity and cytotoxicity testing. &lt;/p&gt; &lt;p&gt; &lt;strong&gt;Results:&lt;/strong&gt; Tinta Cao grape pomace extract was the most potent alpha-glucosidase inhibiting variety and possessed a remarkable antioxidant activity, both properties of which appeared to be correlated. HPLC analysis did not yield an antioxidant responsible for the observed trend. Hence, bioactivity-guided fractionation of the extract was pursued, yielding a pure active compound that was determined to be D-Glucopyranose 6-{(2E)-3-(4-Hydroxyphenyl)prop-2-enoate}, which also exhibited a strong antioxidant activity. Further testing indicated that the compound inhibits alpha-glucosidase and not alpha-amylase, and specifically inhibits the maltase and isomaltase moieties of alpha-glucosidase, in a dose-dependent fashion. The compound was fairly stable under different environmental and storage conditions, and it was also not cytotoxic to animal cells.&lt;/p&gt; &lt;p&gt; &lt;strong&gt;Conclusion:&lt;/strong&gt; Red grape pomace, namely Tinta Cao, is a promising bioresource for the future development of a food-derived antidiabetic agent. At least one component, D-Glucopyranose 6-{(2E)-3-(4-Hydroxyphenyl)prop-2-enoate}, isolated from Tinta Cao grape pomace appears to potently and specifically inhibit mammalian intestinal alpha-glucosidases while exhibiting a notable ability to quench free radicals. It may thus represent an alternative future strategy for diabetes management and a novel antioxidant compound. Pre-clinical and clinical testing will validate the obtained results in vivo.&lt;/p&gt;","abstract_has_math":false,"creators":["Kadouh, Hoda Chaouki"],"institution":null,"degree_name":"Ph.D.","degree_level":"Open Access Dissertation","degree_discipline":"Nutrition and Food Science","degree_department":null,"school":null,"contributors":["Kequan (Kevin) Zhou"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2014,"date_issued":"2014-01-01T08:00:00Z","date_published":"2014-01-01T08:00:00Z","updated_at":"2026-07-24T05:59:33Z","subjects":["Alpha-Glucosidases","Antioxidant","Diabetes","Grape Pomace","Tinta Cao","Alternative and Complementary Medicine","Nutrition","Pharmacology"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[]},"links":{"outbound_url":"https://digitalcommons.wayne.edu/oa_dissertations/889","outbound_label":"Repository record","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Kequan (Kevin) Zhou"]},{"key":"dc:creator","label":"Author","values":["Kadouh, Hoda Chaouki"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2014-01-01T08:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Nutrition and Food Science"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Open Access Dissertation"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Ph.D."]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Alpha-Glucosidases","Antioxidant","Diabetes","Grape Pomace","Tinta Cao","Alternative and Complementary Medicine","Nutrition","Pharmacology"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://digitalcommons.wayne.edu/oa_dissertations/889"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["<p> <strong>Background:</strong> Diabetes is currently a global public health problem affecting people at all ages. Dietary antioxidants have been associated with a reduced risk of type 2 diabetes. Grape pomace contains considerable amounts of polyphenols and it has been reported to exhibit an inhibitory activity against alpha- glucosidases. Alpha-glucosidases, in turn, play a major role in controlling starch digestion and therefore postprandial blood glucose, a target for diabetes management. </p> <p> <strong>Objective:</strong> This study aims to investigate the anti-diabetes potential of a selection of six grape pomaces and prepare and purify active components in the active variety that specifically inhibit intestinal alpha-glucosidases. The study was also designed to evaluate the applicability of the isolated active components as natural inhibitors of alpha-glucosidases. </p> <p> <strong>Methods:</strong> Chambourcin, Merlot, Norton, Petit Verdot, Syrah and Tinta Cao red wine grape pomace extracts were assessed for their rat intestinal alpha-glucosidase inhibiting activity and antioxidant properties via biochemical assays and UV detection. Then, the grape pomace variety shown to potently inhibit the enzyme was subjected to bioactivity-guided fractionation and the isolated active component was identified via analytical chemistry techniques. The characterized compound was then tested for functional food applicability via stability, enzyme specificity and cytotoxicity testing. </p> <p> <strong>Results:</strong> Tinta Cao grape pomace extract was the most potent alpha-glucosidase inhibiting variety and possessed a remarkable antioxidant activity, both properties of which appeared to be correlated. HPLC analysis did not yield an antioxidant responsible for the observed trend. Hence, bioactivity-guided fractionation of the extract was pursued, yielding a pure active compound that was determined to be D-Glucopyranose 6-{(2E)-3-(4-Hydroxyphenyl)prop-2-enoate}, which also exhibited a strong antioxidant activity. Further testing indicated that the compound inhibits alpha-glucosidase and not alpha-amylase, and specifically inhibits the maltase and isomaltase moieties of alpha-glucosidase, in a dose-dependent fashion. The compound was fairly stable under different environmental and storage conditions, and it was also not cytotoxic to animal cells.</p> <p> <strong>Conclusion:</strong> Red grape pomace, namely Tinta Cao, is a promising bioresource for the future development of a food-derived antidiabetic agent. At least one component, D-Glucopyranose 6-{(2E)-3-(4-Hydroxyphenyl)prop-2-enoate}, isolated from Tinta Cao grape pomace appears to potently and specifically inhibit mammalian intestinal alpha-glucosidases while exhibiting a notable ability to quench free radicals. It may thus represent an alternative future strategy for diabetes management and a novel antioxidant compound. Pre-clinical and clinical testing will validate the obtained results in vivo.</p>"]},{"key":"dc:title","label":"Title","values":["Isolation And Characterization Of Natural Alpha-Glucosidase Inhibitors From Antioxidant Rich Red Wine Grapes (vitis Vinifera)"]}]}],"canonical_facts":{"dc:contributor":["Kequan (Kevin) Zhou"],"dc:creator":["Kadouh, Hoda Chaouki"],"dc:date.available":["2014-01-01T08:00:00Z"],"dc:description.abstract":["<p> <strong>Background:</strong> Diabetes is currently a global public health problem affecting people at all ages. Dietary antioxidants have been associated with a reduced risk of type 2 diabetes. Grape pomace contains considerable amounts of polyphenols and it has been reported to exhibit an inhibitory activity against alpha- glucosidases. Alpha-glucosidases, in turn, play a major role in controlling starch digestion and therefore postprandial blood glucose, a target for diabetes management. </p> <p> <strong>Objective:</strong> This study aims to investigate the anti-diabetes potential of a selection of six grape pomaces and prepare and purify active components in the active variety that specifically inhibit intestinal alpha-glucosidases. The study was also designed to evaluate the applicability of the isolated active components as natural inhibitors of alpha-glucosidases. </p> <p> <strong>Methods:</strong> Chambourcin, Merlot, Norton, Petit Verdot, Syrah and Tinta Cao red wine grape pomace extracts were assessed for their rat intestinal alpha-glucosidase inhibiting activity and antioxidant properties via biochemical assays and UV detection. Then, the grape pomace variety shown to potently inhibit the enzyme was subjected to bioactivity-guided fractionation and the isolated active component was identified via analytical chemistry techniques. The characterized compound was then tested for functional food applicability via stability, enzyme specificity and cytotoxicity testing. </p> <p> <strong>Results:</strong> Tinta Cao grape pomace extract was the most potent alpha-glucosidase inhibiting variety and possessed a remarkable antioxidant activity, both properties of which appeared to be correlated. HPLC analysis did not yield an antioxidant responsible for the observed trend. Hence, bioactivity-guided fractionation of the extract was pursued, yielding a pure active compound that was determined to be D-Glucopyranose 6-{(2E)-3-(4-Hydroxyphenyl)prop-2-enoate}, which also exhibited a strong antioxidant activity. Further testing indicated that the compound inhibits alpha-glucosidase and not alpha-amylase, and specifically inhibits the maltase and isomaltase moieties of alpha-glucosidase, in a dose-dependent fashion. The compound was fairly stable under different environmental and storage conditions, and it was also not cytotoxic to animal cells.</p> <p> <strong>Conclusion:</strong> Red grape pomace, namely Tinta Cao, is a promising bioresource for the future development of a food-derived antidiabetic agent. At least one component, D-Glucopyranose 6-{(2E)-3-(4-Hydroxyphenyl)prop-2-enoate}, isolated from Tinta Cao grape pomace appears to potently and specifically inhibit mammalian intestinal alpha-glucosidases while exhibiting a notable ability to quench free radicals. It may thus represent an alternative future strategy for diabetes management and a novel antioxidant compound. Pre-clinical and clinical testing will validate the obtained results in vivo.</p>"],"dc:identifier":["https://digitalcommons.wayne.edu/oa_dissertations/889"],"dc:subject":["Alpha-Glucosidases","Antioxidant","Diabetes","Grape Pomace","Tinta Cao","Alternative and Complementary Medicine","Nutrition","Pharmacology"],"dc:title":["Isolation And Characterization Of Natural Alpha-Glucosidase Inhibitors From Antioxidant Rich Red Wine Grapes (vitis Vinifera)"],"thesis:degree_discipline":["Nutrition and Food Science"],"thesis:degree_level":["Open Access Dissertation"],"thesis:degree_name":["Ph.D."]},"updated_at":"2026-07-24T05:59:33Z"}